Mrs. Wendy Lynn Florus, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 515 W Main St, Weimar, TX 78962 Phone: 979-725-6009 |
Kassie Chaffin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1189 Highway 90, Weimar, TX 78962 Phone: 979-725-6300 |
News Archive
Congressional Democrats continue to divvy up blame for the stalled health overhaul, with fingers now pointed toward centrist Democrats and Republicans, President Barack Obama or even White House Chief of Staff Rahm Emanuel, depending on the blamer's perspective.
DUSA Pharmaceuticals, Inc.(R)( )(Nasdaq: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that it has been named to Deloitte's Technology Fast 500 list. For the second consecutive year, Deloitte recognized DUSA as one of the Top 500 fastest growing technology, media, telecommunications and life sciences companies in North America in terms of percentage revenue growth over a five year period.
A simple word-training program has been found to restore key words in people with a type of dementia that attacks language and our memory for words.
Biotech company Pharming Group NV has announced that the US Food and Drug Administration (FDA) has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection (AMR) in kidney transplantation. Dr. Hans Sollinger of the University of Wisconsin, Madison will conduct the clinical trial with rhC1INH under an Investigator IND from the FDA.
› Verified 2 days ago